Usefulness of HE4 protein in differentiation of pelvic masses in woman

Andrzej Brenk; Piotr Bodzek; Mikołaj Baliś; Aleksandra Barbachowska; Iwona Janosz; Anita Olejek

doi:10.5114/pm.2019.84154

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2019
vol. 18

Send email

Copy url:

abstract:

Original paper

Usefulness of HE4 protein in differentiation of pelvic masses in woman

Andrzej Brenk

¹

,

Piotr Bodzek

¹

,

Mikołaj Baliś

¹

,

Aleksandra Barbachowska

¹

,

Iwona Janosz

¹

,

Anita Olejek

¹

Department of Gynaecology, Obstetrics and Oncological Gynaecology, Medical University of Silesia, Poland

Menopause Rev 2019; 18(1): 27-32

DOI: https://doi.org/10.5114/pm.2019.84154

Online publish date: 2019/04/09

View full text Get citation

PlumX metrics:

Introduction
HE4 protein (human epididymis protein-4), which is the fourth subfraction of human epithelial protein, is a glycoprotein widely used as a tumor marker in ovarian cancer. If was first discovered in the epididymal epithelium and recognized as a protease inhibitor contributing to sperm maturation. The plasma HE4 concentration may also be increased in gynecological pathologies other than ovarian cancer.

Material and methods
The study was conducted between 2016 and 2017 among patients hospitalized in the Academic Department of Gynaecology. A total of 191 women were examined. Depending on the type of pathology which was the reason for hospitalization, 4 groups of patients were identified in the study. The first of these included 30 patients with ovarian cancer, the second 33 patients with benign ovarian lesion, the third 50 patients with endometrial cancer, and the fourth 28 patients with leiomyomas.

Results
The highest concentration of HE4 protein was found in women with ovarian cancer, and it was statistically significantly higher compared to all other groups. Lower HE4 protein concentration than in women with ovarian cancer was reported in women with endometrial cancer, but it was statistically significantly higher compared to patients with uterine fibroids.

Conclusions
This marker may have significant clinical value in the differentiation of benign ovarian pathology from ovarian cancer. The study confirms the validity of using HE4 results in the assessment of potential malignancy of ovarian and endometrial lesions.

keywords:

Usefulness of HE4 protein in differentiation of pelvic masses in woman

Andrzej Brenk 1 , Piotr Bodzek 1 , Mikołaj Baliś 1 , Aleksandra Barbachowska 1 , Iwona Janosz 1 , Anita Olejek 1

HE4 protein, ovarian cancer, endometrial cancer, uterine fibroids

Andrzej Brenk

¹

,

Piotr Bodzek

¹

,

Mikołaj Baliś

¹

,

Aleksandra Barbachowska

¹

,

Iwona Janosz

¹

,

Anita Olejek

¹